Pancreatic Cancer, Stage IB
1 clinical trials · Condition
◉ Watch Pancreatic Cancer, Stage IB
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer (NCT05562297) | Shanghai Zhongshan Hospital | 2025-03-20 |
Track Pancreatic Cancer, Stage IB automatically
Every clearance here is in the API, with alerts when new ones post.